U.S. Beverage Stock News

Charles Schwab reported that at the end of July, client assets increased 15% year-over-year and 2% month-over-month, with core net new assets reaching US$46.9 billion, up 62% from the previous period. This surge in client assets and net inflows reflects continued growth in Schwab’s customer base and may indicate strengthening engagement across its financial services. We'll explore how the significant increase in net new assets may influence the company's long-term investment narrative and...

On August 4, 2025, ChoiceOne Bank announced the transition of its investment program to the Ameriprise Financial Institution Group, now operating as ChoiceOne Wealth Management with approximately US$780 million in assets managed across Michigan by 10 financial advisors and two support staff. This move broadens Ameriprise Financial’s institutional footprint and gives ChoiceOne clients access to expanded advisory services, investment products, and digital client engagement tools. We'll look at...

Earlier this week, Enterprise Products Partners responded to a crude oil leak at its southeast Houston terminal, which was quickly contained with no reported injuries or offsite impact, as cleanup and collaboration with regulators began immediately. An important insight is that this operational incident unfolded while the company was in the midst of advancing US$6 billion in ongoing growth projects, highlighting the balance between operational risks and a substantial expansion plan. We’ll...

BigBear.ai recently announced the successful integration of its Pangiam Threat Detection platform with Smiths Detection's HI-SCAN 6040 CTiX systems, bringing real-time automated security screening to airports worldwide and marking a key step towards modernizing aviation and border security. This rollout, combined with new airport trials, highlights BigBear.ai’s ability to rapidly deploy advanced AI technologies in critical security environments following a period of substantial financial...

Guardant Health recently reported second quarter results showing strong demand across its core oncology and screening businesses, with management raising full-year revenue guidance on the back of rapid product adoption and expanding biopharma partnerships. An interesting insight is that despite ongoing operating losses and continued reinvestment, the revised outlook reflected management's confidence in sustained growth, coinciding with positive sector sentiment following speculation of lower...

NasdaqGS:FELE 1 Year Share Price vs Fair Value Explore Franklin Electric's Fair Values from the Community and select...

H.B. Fuller Company's ( NYSE:FUL ) price-to-earnings (or "P/E") ratio of 31.7x might make it look like a strong sell...

NasdaqGS:CRWD 1 Year Share Price vs Fair Value Explore CrowdStrike Holdings's Fair Values from the Community and select...

Investors were underwhelmed by the solid earnings posted by QuinStreet, Inc. ( NASDAQ:QNST ) recently. We did some...

NasdaqGM:ALT 1 Year Share Price vs Fair Value Explore Altimmune's Fair Values from the Community and select yours...

Quad/Graphics, Inc. ( NYSE:QUAD ) stock is about to trade ex-dividend in three days. The ex-dividend date is one...

NasdaqGS:PODD 1 Year Share Price vs Fair Value Explore Insulet's Fair Values from the Community and select yours...

The Timken Company ( NYSE:TKR ) stock is about to trade ex-dividend in four days. The ex-dividend date is one business...

Worthington Enterprises, Inc. ( NYSE:WOR ) has announced that it will be increasing its periodic dividend on the 29th...

CytomX Therapeutics, Inc. ( NASDAQ:CTMX ) shareholders won't be pleased to see that the share price has had a very...

NasdaqGM:AQST 1 Year Share Price vs Fair Value Explore Aquestive Therapeutics's Fair Values from the Community and...

NasdaqGS:PRTS 1 Year Share Price vs Fair Value Explore CarParts.com's Fair Values from the Community and select yours...

Astera Labs (ALAB) recently reported a significant positive shift in its financial performance, announcing a quarterly net income of $51 million and a strong sales increase, which likely played a role in the stock's impressive 114% rise over the past month. The company's improved earnings, coupled with positive guidance for the coming quarter, provided strong momentum. This standout performance was particularly notable against a backdrop of modest market gains, as broader indexes saw mixed...

Tencent Music Entertainment Group (TME) recently reported significant earnings growth for Q2 2025, with revenues rising to CNY 8,442 million and net income reaching CNY 2,409 million, accompanied by a 56% increase in its share price over the last quarter. The earnings improvement reflects strong performance, which coincides with record highs in broader market indices and renewed optimism after promising consumer price data. Although inflation concerns and interest rate uncertainties continue...

Symbotic (SYM) recently unveiled its next-generation storage technology, promising significant enhancements in warehouse automation. This announcement, combined with a positive revenue forecast for Q4 2025 ranging from $590 million to $610 million, aligns with the company's Q3 results, which showed a revenue increase to $592 million from $470 million the previous year, despite a consistent net loss per share. This news complements the broader market uptick of 1.9% over the last week, but...

Axon Enterprise (AXON) recently showcased its Q2 results with revenue climbing to $669 million, though net income and earnings per share experienced declines. The company also raised its full-year 2025 revenue guidance, reflecting confidence in future growth prospects. Despite completing part of their share buyback plan, no shares were repurchased in the latest quarter. Over the past quarter, Axon Enterprise's stock rose by 5.1%. This movement aligns with broader market trends where indices...

Tapestry (TPR) has recently reported mixed financial results, revealing a 36% share price move over the last quarter. Despite an increase in sales, the company faced significant losses and a decline in net income, yet balanced these challenges with a commitment to shareholder value by increasing dividends by 14%. The addition to several Russell indices and the newly secured debt financing for various corporate purposes likely supported the stock's positive shift. Meanwhile, broader market...

Strategy (MSTR) recently weathered a price decline of 2.48% over the last quarter. This performance could be contextualized by the company's August name change from MicroStrategy to Strategy Inc., potentially impacting investor perception. Meanwhile, the announcement of a $4.2 billion fixed-income offering and robust earnings results in July may have added weight to the broader market dynamics. While the Dow Jones and other indices experienced record highs, Strategy's decline aligns with...

STERIS (STE) saw an 12% increase in its share price over the past week, a period marked by significant corporate developments and strong earnings results. The company announced the appointment of Karen L. Burton as the new CFO following Michael J. Tokich's resignation, which could have implications for investor sentiment given the shakeup in the financial leadership. Furthermore, revised earnings guidance indicated higher expected revenue growth, potentially boosting investor confidence...